Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
12 drugs across 1 manufacturers|0 Generic,12 Brand
Total Drugs
12
0G / 12B
Manufacturers
1
Avg $532.4490/unit
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
12 flat
of 12 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
1 manufacturer producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MOUNJARO 2.5 MG/0.5 ML PEN tirzepatide | $538.7954 per ML | — |
MOUNJARO 5 MG/0.5 ML PEN tirzepatide | $538.7438 per ML | — |
MOUNJARO 7.5 MG/0.5 ML PEN tirzepatide | $538.7397 per ML | — |
MOUNJARO 10 MG/0.5 ML PEN tirzepatide | $538.7092 per ML | — |
MOUNJARO 15 MG/0.5 ML PEN tirzepatide | $538.6398 per ML | — |
MOUNJARO 12.5 MG/0.5 ML PEN tirzepatide | $538.5770 per ML | — |
ZEPBOUND 2.5 MG/0.5 ML PEN tirzepatide | $526.3087 per ML | — |
ZEPBOUND 5 MG/0.5 ML PEN tirzepatide | $526.2940 per ML | — |
ZEPBOUND 7.5 MG/0.5 ML PEN tirzepatide | $526.1985 per ML | — |
ZEPBOUND 12.5 MG/0.5 ML PEN tirzepatide | $526.1832 per ML | — |
ZEPBOUND 15 MG/0.5 ML PEN tirzepatide | $526.1783 per ML | — |
ZEPBOUND 10 MG/0.5 ML PEN tirzepatide | $526.0206 per ML | — |